Medical Design and Outsourcing Archives - Page 44 of 154

COVID-19’s mechanisms are becoming clearer, Abbott’s heart failure CMO says

Dr. Philip Adamson is chief medical officer of Abbott’s heart failure business [Photo courtesy of Abbott]

We still don’t fully understand why the SARS-CoV-2 virus is so transmissible and causes severe disease in some people but not others.

But Dr. Philip Adamson, chief medical officer of Abbott’s heart failure business, said he’s amazed by how quickly we’re learning about COVID-19, building off our prior knowledge of coronaviruses and other viral pathogens.

“We have more of a handle on the mechanisms, and that’s where I think we are beginning to have hope for clarity,” he said. “In just about every disease that we are able to treat, we develop those treatments because we understand the fundamental mechanism of the disease.”

Adamson warned of increasing rates of heart and lung failure due to COVID-19 when Medical Design & Outsourcing interviewed h…

Junkosha plans new medical plant by 2025 as expansion strategy accelerates

NEWS RELEASE: Junkosha Plans New Medical Plant by 2025 as Expansion Strategy Accelerates

A Junkosha associate assessing product [Photo courtesy of Junkosha]

Japanese fluoropolymer manufacturer Junkosha, best known for its peelable FEP Heat Shrink Tubing and PTFE Liners, is staying true to its word by actively expanding capacity across its interventional medical component manufacturing sites. The company has announced the building of a new facility in Kasama, Japan, planned for 2025. Junkosha’s target is to implement a four times growth across the PTFE Liner products and three times growth across its peelable FEP Heat Shrink Tubing portfolio. An announcement to meet customer needs was made last year and the ramping up of capacity is now underway with onboarding in February. The rollout of new equipment will continue over the next 18 months until capacity goals have been hit.

As a sector, medical technology is no…

BioInteractions launches expanded medical product development partnership offering at MD&M West

NEWS RELEASE: BioInteractions launches expanded medical product development partnership offering at MD&M West

[Photo courtesy of BioInteractions]

Organizations planning to bring a medical device to market should consider the benefits teams gain by using a single high-end consultancy as they navigate the entire product development process.

BioInteractions, a leading U.K. biomaterial technology company, is launching its expanded Product Pathway Partnership service incorporating bespoke coatings, optimized application and tooling, testing, regulatory support and commercial production, at the world’s largest medical design and manufacturing event, MD&M West. The company, which is responsible for creating and developing the ground-breaking coating technology for medical devices TridAnt®, as well as the widely proven Astute® and Assist™ solutions, is announcing this new service aimed at advancing organ…

Teamvantage launches new parent company Velosity

NEWS RELEASE: Teamvantage Launches New Parent Company: Velosity

Teamvantage, an industry leader in state-of-the-art tool design and manufacture, injection molding, precision machining and contract manufacturing for the medical device market for more than 50 years, announced today from MD&M West 2023 the launch of its new parent company, Velosity.

Velosity will now represent the entire family of brands and the full range of services offered under one umbrella, including Teamvantage, MMD Medical, Custom Mold & Design, CMD Precision Manufacturing Group, and Paradigme Engineering.

Velosity CEO Dave Hemink [Photo courtesy of Velosity

“As our capabilities and market footprint have grown over the past year, it was the perfect time to align the brand name with the way in which we operate,” said Velosity CEO Dave Hemink. “Although we will have a new name, our mission remains unchanged: to accelerate innov…

Edwards Lifesciences names Secant Group as its supplier of the year

NEWS RELEASE: Edwards Lifesciences Awards Secant Group 2022 Supplier of the Year

Secant Group, a leading innovator in the design, development, and manufacture of implantable medical textile components for medical devices, has been named 2022 Supplier of the Year by Edwards Lifesciences, the global leader in patient-focused medical innovations for structural heart disease and critical care and surgical monitoring.

“We’re thrilled to receive this prestigious award from Edwards Lifesciences. This is a testament to Secant’s rigorous quality standards and multidisciplinary teamwork that enables Edwards Lifesciences to advance their innovative, life-saving devices with our implantable textile solutions. We’re proud to be a long-serving partner of Edwards and look forward to collaborating with them on new solutions for years to come,” said Karen West, CEO, Solesis, parent company of Secant Group.

In 2022, Secant Group was also the first-ever supplier awarded Gold Stat…

Auxo Investment Partners buys Morgan Royce Industries and TACK Electronics

NEWS RELEASE: Auxo Investment Partners Bolsters its Wire Harness and Cable Platform, Golden State Assembly, with the Acquisitions of Morgan Royce Industries and TACK Electronics Morgan Royce Industries is a manufacturer of cable assemblies and box builds for the semiconductor equipment industry. TACK Electronics is a manufacturer of custom wire harnesses and cable assemblies for customers in the aerospace and defense, gaming, medical, transportation and battery/energy equipment industries. Acquisitions follow Auxo’s recent purchase of Golden State Assembly, a vertically integrated wire/cable assembly and harness manufacturer. Latest deals are part of Auxo’s continued acquisition strategy to build a diversified leader in the wire harness industry. Acquisition of TACK brings together Auxo’s two funds, Auxo Growth Holdings and the Michigan Opportunity Fund, into a common wire harness platform.

Private investment firm Auxo Investment Partners announced that it has acquired Mor…

New ‘ultrasound tornado’ device breaks down blood clots

[Image courtesy of North Carolina State University]

Researchers at say a new tool and technique using “vortex ultrasound” could potentially break down blood clots in the brain.

This sort of ultrasonic tornado eliminated clots formed in an in vitro model of cerebral venous sinus thrombosis (CVST). The researchers, based at North Carolina State University, say it worked more quickly than existing techniques.

“Our previous work looked at various techniques that use ultrasound to eliminate blood clots using what are essentially forward-facing waves,” said Xiaoning Jiang, co-corresponding author of a paper on the work. “Our new work uses vortex ultrasound, where the ultrasound waves have a helical wavefront.

Jiang, the Dean F. Duncan Professor of Mechanical and Aerospace Engineering at N.C. State, said the ultrasound “is swirling as it moves forward.” Because of the shear stress…

Stratasys has its first FDA-cleared medical device

3D-printed dentures printed with the new TrueDent resin [Image courtesy of Stratasys]

Stratasys (NASDAQ: SSYS) today introduced its TrueDent resin for making 3D-printed dentures.

TrueDent is the first FDA-cleared medical device for the company, which is based in Eden Prairie, Minnesota and Rehovot, Isreal. The Class II dental resin is made specifically for the fabrication of dental appliances, including removable dentures.

The company had the resin developed for printing exclusively with the Stratasys J5 DentaJet 3D printer and GrabCAD Print software platform.

According to Stratasys, the offering will enable dental labs to scale manufacturing by simplifying workflow and reducing processing time for dentures, while achieving a personalized, highly aesthetic dental appliance.

Stratasys sees a multibillion-dollar opportunity to take the stress out of making dentures

Stratasys says advantages i…

Honeywell introduces new bio-fiber for cardiovascular and orthopedic devices

NEWS RELEASE: Honeywell introduces new ultra-fine denier medical grade bio fiber for cardiovascular and orthopedic devices

Honeywell’s Spectra UF BIO fiber in 25 dtex [Photo courtesy of Honeywell]

New technology enables smaller, lighter and more durable minimally invasive surgical device design

Honeywell today announced the addition of a new ultra-fine denier fiber to its Spectra ® Medical Grade (MG) BIO fiber portfolio. Spectra ® Ultra Fine (UF) BIO fiber, now available in 25 decitex (dtex), enables minimally invasive cardiovascular and orthopedic device design and helps increase device longevity, given it is a stronger fiber compared to polyester, nylon or other technologies used.

Compared with conventional polyethylene fiber, Honeywell’s Spectra MG BIO fibers are made of ultra- high molecular weight polyethylene (UHMWPE), which is ultra-lightweight, ultra-high strength and manufactured through a uniq…

Qosina appoints former EssilorLuxottica exec as its EVP

Lee Pochter [Image courtesy of Qosina]

Qosina announced today that it’s appointed Lee Pochter as its executive vice president.

Pochter has more than 20 years of expertise in product strategy, business development, sales, marketing and supply chain management. Most recently, he was VP of the Alternative Lens Group at EssilorLuxottica.

“I look forward to the guidance Lee will bring to our team and the positive impact he will make in our organization,” Qosina CEO Scott Herskovitz said in a news release. “He is an accomplished leader with the vision and executive experience to help us implement our robust strategic plan and goals. His diverse background will be a valuable asset to Qosina.”

Pochter will lead Ronkonkoma, New York–based Qosina’s sales, finance, marketing, product development,…

Trelleborg to expand biopharma manufacturing footprint in Europe

NEWS RELEASE: Trelleborg to Expand its BioPharma Manufacturing Footprint in Europe

This rendering shows Trelleborg’s plans for its Malta expansion. [Illustration courtesy of Trelleborg]

Trelleborg Healthcare & Medical announces a substantial investment to expand its European biopharmaceutical manufacturing capabilities in Malta. This follows a multimillion-dollar investment initiated in 2022 to expand biopharma capacities in North America.

Linda Muroski, President of Trelleborg Healthcare & Medical, says: “The site will initially add over 4,000 square feet of cleanroom space and focus on silicone tubing and braided hose with options to extend capabilities in the future. This is our second biopharma-focused manufacturing space alongside our BioPharma Center of Excellence in Northborough, Massachusetts in the U.S.”

The Malta site is one of Trelleborg’s largest manufacturing sites in Europe wi…

Ulbrich expands Braid Wire Accelerator program

[Image courtesy of Ulbrich]

Ulbrich Specialty Wire Products (USWP) announced that it expanded its Braid Wire Accelerator program by making it available in Europe.

North Haven, Connecticut-based Ulbrich’s e-commerce solution rapidly delivers round and flat wire materials for manufacturing needs. Customers can, through just a few clicks, see alloys in stock, select materials and add products to their cart.

In February 2022, the company launched its e-commerce platform in North America. In a news release, Ulbrich said that it made the procurement tool available in Europe now following its successful North American rollout.

“I’m thrilled that the Braid Wire Accelerator has launched in Europe,” said Christian Prischmann, Ulbrich of Austria’s director of business development. “It will be easier than ever for our customers to source high-quality wire and beat their competitors to market.”

…